Ritu Salani MD

Ritu Salani MD
Asst ProfessorCollege of Medicinesalani.2@osu.edu
SLM 210 Starling Loving Hall 320 W 10th Avenue Columbus Ohio 43210
Phone:614-293-7642Fax: 614-293-9078
  • Cancer Control

Current Publications

  • Eisenhauer ELFeasibility of Interval Cytoreduction Following Neoadjuvant Chemotherapy With Carboplatin, Weekly Paclitaxel, and Bevacizumab for Advanced Ovarian Cancer-A Phase 1 Study.Int J Gynecol Cancer 3/19/2014
  • Crafton SMReply.Am J Obstet Gynecol 2/11/2014
  • Liang MI, Rosen MA, Rath KS, Clements AE, Backes FJ, Eisenhauer EL, Salani R, O'Malley DM, Fowler JM, Cohn DEReducing readmissions after robotic surgical management of endometrial cancer:A potential for improved quality care.Gynecol Oncol in press 10/4/2013
  • Tiwari P, Coriddi M, Salani R, Povoski SPBreast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options.World J Surg Oncol 11(1) 237 9/22/2013
  • Salani RSurvivorship planning in gynecologic cancer patients.Gynecol Oncol 130(2) 389-97 8/1/2013
  • Brothers BM, Easley A, Salani R, Andersen BLDo survivorship care plans impact patients' evaluations of care? A randomized evaluation with gynecologic oncology patients.Gynecol Oncol 129(3) 554-8 6/1/2013
  • Backes FJ, Richardson DL, McCann GA, Smith B, Salani R, Eisenhauer EL, Fowler JM, Copeland LJ, Cohn DE, O'Malley DMShould bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Int J Gynecol Cancer 23(5) 833-8 6/1/2013
  • McCann GA, Boutsicaris CE, Preston MM, Backes FJ, Eisenhauer EL, Fowler JM, Cohn DE, Copeland LJ, Salani R, O'Malley DMNeuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease.Gynecol Oncol 129(1) 135-9 4/1/2013
  • Rath KS, Loseth D, Muscarella P, Phillips GS, Fowler JM, O'Malley DM, Cohn DE, Copeland LJ, Eisenhauer EL, Salani ROutcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer.Gynecol Oncol 129(1) 103-6 4/1/2013
  • McCann GA, Taege SK, Boutsicaris CE, Phillips GS, Eisenhauer EL, Fowler JM, O'Malley DM, Copeland LJ, Cohn DE, Salani RThe impact of close surgical margins after radical hysterectomy for early-stage cervical cancer.Gynecol Oncol 128(1) 44-8 1/1/2013
  • McCann GA, Smith B, Backes FJ, Rath K, Chacko S, Salani R, Eisenhauer E, Fowler J, Cohn D, O'Malley DRecurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?Gynecol Oncol 127(2) 362-6 11/1/2012
  • Salani R, O'Malley DMHere it comes....the role of cost-effective analysis.Gynecol Oncol 127(2) 265-6 11/1/2012
  • Salani R, Andersen BLGynecologic care for breast cancer survivors: assisting in the transition to wellness.Am J Obstet Gynecol 206(5) 390-7 5/1/2012
  • Quick AM, Seamon LG, Abdel-Rasoul M, Salani R, Martin DSexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma.Int J Gynecol Cancer 22(4) 703-8 5/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu